These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 24053688)
61. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides. Sinclair D; Stevens JM Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028 [TBL] [Abstract][Full Text] [Related]
62. Polyarteritis nodosa and antiglomerular basement membrane disease without antineutrophil cytoplasm antibodies. Kirkland GS; Savige J; Sinclair RA; Hennessy O Am J Nephrol; 1996; 16(5):442-5. PubMed ID: 8886183 [TBL] [Abstract][Full Text] [Related]
63. [Avidity of anti-glomerular basement membrane autoantibodies was associated with renal pathological damage]. Cui Z; Zhao MH Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):903-7. PubMed ID: 16029529 [TBL] [Abstract][Full Text] [Related]
64. C1q A08 Is a Half-Cryptic Epitope of Anti-C1q A08 Antibodies in Lupus Nephritis and Important for the Activation of Complement Classical Pathway. Wu WJ; Tan Y; Liu XL; Yu F; Zhao MH Front Immunol; 2020; 11():848. PubMed ID: 32536911 [TBL] [Abstract][Full Text] [Related]
65. A "double-seropositive" Vasculitis for antiglomerular basement membrane antibodies and antineutrophil cytoplasmic antibody, and multiple myeloma, all three with simultaneous diagnosis of renal involvement, common pathophysiology, or pure coincidence? first case in the World. Chettati M; Adnouni A; Bouchemla N; Anibar S; Fadili W; Laouad I Saudi J Kidney Dis Transpl; 2019; 30(4):953-959. PubMed ID: 31464254 [TBL] [Abstract][Full Text] [Related]
66. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity. Emad G; Al-Barshomy SM Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906 [TBL] [Abstract][Full Text] [Related]
67. Anti-C1q antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephritis. Chen Z; Wang GS; Wang GH; Li XP Clin Rheumatol; 2012 Sep; 31(9):1323-9. PubMed ID: 22696012 [TBL] [Abstract][Full Text] [Related]
68. Anti-GBM disease: predictive value of clinical, histological and serological data. Herody M; Bobrie G; Gouarin C; Grünfeld JP; Noel LH Clin Nephrol; 1993 Nov; 40(5):249-55. PubMed ID: 8281713 [TBL] [Abstract][Full Text] [Related]
69. Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease. Liang D; Liang S; Xu F; Zhang M; Li X; Tu Y; Liu Z; Zeng C J Clin Pathol; 2019 Jan; 72(1):31-37. PubMed ID: 30315136 [TBL] [Abstract][Full Text] [Related]
70. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes. Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y Front Immunol; 2020; 11():2073. PubMed ID: 32983156 [No Abstract] [Full Text] [Related]
71. Current status and issues of C1q nephropathy. Mii A; Shimizu A; Masuda Y; Fujita E; Aki K; Ishizaki M; Sato S; Griesemer A; Fukuda Y Clin Exp Nephrol; 2009 Aug; 13(4):263-274. PubMed ID: 19373520 [TBL] [Abstract][Full Text] [Related]
72. Crescentic transformation in primary membranous glomerulopathy: association with anti-GBM antibody. Nayak SG; Satish R Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):599-602. PubMed ID: 17951950 [TBL] [Abstract][Full Text] [Related]
73. Characteristics and Outcomes of Patients with Anti-Glomerular Basement Membrane Antibody Disease and Anti-Neutrophil Cytoplasmic Antibodies. Balderia PG; Andeen N; Jefferson JA Curr Rheumatol Rev; 2019; 15(3):224-228. PubMed ID: 29766817 [TBL] [Abstract][Full Text] [Related]
74. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Levy JB; Hammad T; Coulthart A; Dougan T; Pusey CD Kidney Int; 2004 Oct; 66(4):1535-40. PubMed ID: 15458448 [TBL] [Abstract][Full Text] [Related]
75. Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor. Dougan T; Levy JB; Salama A; George AJ; Pusey CD Clin Exp Immunol; 2002 Jun; 128(3):555-61. PubMed ID: 12067312 [TBL] [Abstract][Full Text] [Related]
77. Spontaneous recovery from early glomerular inflammation is associated with resistance to anti-GBM glomerulonephritis: tolerance and autoimmune tissue injury. Robertson J; Wu J; Arends J; Zhou C; Adrogue HE; Chan JT; Lou Y J Autoimmun; 2008 Jun; 30(4):246-56. PubMed ID: 18054199 [TBL] [Abstract][Full Text] [Related]
78. Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Uwatoko S; Gauthier VJ; Mannik M Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):268-73. PubMed ID: 1914260 [TBL] [Abstract][Full Text] [Related]
79. A 25-year experience with pediatric anti-glomerular basement membrane disease. Williamson SR; Phillips CL; Andreoli SP; Nailescu C Pediatr Nephrol; 2011 Jan; 26(1):85-91. PubMed ID: 20963446 [TBL] [Abstract][Full Text] [Related]
80. Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease. Li JN; Cui Z; Wang J; Hu SY; Jia XY; Guan Z; Chen M; Xie C; Zhao MH Clin J Am Soc Nephrol; 2016 Apr; 11(4):568-75. PubMed ID: 26813562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]